TLTatyana E. Lavrova

Tatyana E. Lavrova

*This is an algorithmically generated author record based on publicly available information.

Tatyana E. Lavrova has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical and Economic Effectiveness of an Amino Acid Formula with a Synbiotic Component in infants with Cow’s milk Protein Allergy

    by Leyla S. Namazova-Baranova, Ivan S. Krysanov, Ekaterina V. Makarova, Victoria Yu. Ermakova, Tatyana E. Lavrova, Л. С. Намазова-Баранова, И. С. Крысанов, Е. В. Макарова, В. Ю. Ермакова, Т. Е. Лаврова

    Background . The use of amino acid formulas (AAF) in severe cow’s milk protein allergy (CMPA) is a generally accepted standard of care for infants. A promising strategy for CMPA control is modulation of the gut microbiota through a synbiotic complex. The high cost of AAF reduces family compliance and limits the effectiveness of therapy, while the lack of clinical and economic evaluations of AAF use in the Russian Federation does not allow for an objective assessment of the reduction in the overall disease burden. The aim of the study was to conduct a pharmacoeconomic assessment of the use of amino acid-based therapeutic formulas in infants with CMPA in the Russian healthcare system. Materials and methods . The study included AAF with and without a synbiotic complex, registered for use in the Russian Federation as of the end of 2025 in infants from birth with severe CMPA: Neocate Syneo, Alfare Amino, Nutrilak Premium Amino. A cost-effectiveness analysis and one-way sensitivity analysis were performed. Results . Annual costs of diet therapy amounted to 414,624 rubles for Neocate Syneo, 394,848 rubles for Alfare Amino, and 331,968 rubles for Nutrilak Premium Amino. At the same time, the use of Neocate Syneo was associated with a significant reduction in the cost of treating complications: 20,698.19 rubles versus 49,261.56 rubles with conventional AAF (58% savings). Total direct medical costs with Neocate Syneo amounted to 435,322.19 rubles per year, which was higher than with Nutrilak Premium Amino (+54,092.63 rubles) and comparable to the costs of Alfare Amino (–8,787.37 rubles). The cost-effectiveness analysis showed that the cost of one case of complete symptom resolution was minimal with Neocate Syneo (640,179.70 rubles), which is 34.5–43.8% more cost-effective compared to other AAF. The advantage of Neocate Syneo was maintained even with an increase in the product price of up to 52% or a decrease in clinical effectiveness of 34%. Conclusion . The use of Neocate Syneo in infants with CMPA is economically feasible and has a clinical advantage over AAF without a synbiotic component. Neocate Syneo contributes to improved clinical outcomes, reduced risk of complications, improved quality of life and cost optimization in the Russian healthcare system.

  • Open Access

    Nutritional tactics for premature infants with different gestational ages during the neonatal period: A shifting paradigm of enteral feeding in hospitals

    by E.V. Grosheva, O.V. Mantush, V.V. Zubkov, T.E. Lavrova, Llc Nutricia, I.A. Kazantseva, E.E. Kuznetsova, А.A. Kozlovskaya, E.I. Urlapova, M.I. Skorodelova

    Выбор нутритивной тактики для недоношенных детей разного гестационного возраста в неонатальном периоде с позиции смены парадигмы энтерального

  • Non-IgE-mediated gastrointestinal food allergy in children. Diagnostics, differential diagnostics, tactics of diet therapy

    by S.G. Makarova, T.E. Lavrova, G.A. Novik

    In routine pediatric practice, non-IgE-mediated forms of gastrointestinal food allergy are still poorly recognized. This is due to the variety of clinical manifestations, the lack of reliable laboratory diagnostic methods, the unclear association with time, and the causal relationship with the allergen. Immature barrier mechanisms and early transition to formula feeding increase the penetration of allergen proteins, leading to sensitization. The article discusses three clinical forms of non-IgE-mediated gastrointestinal food allergy in children: food protein-induced enterocolitis syndrome, food protein enteropathy, and food protein-induced proctocolitis. In these cases, diet is a universal diagnostic and therapeutic measure. Eliminating the allergen allows for immunological reset and the induce the food tolerance. Therefore, strict adherence to elimination diets is crucial. The article also provides a differential diagnosis based on the level of allergic inflammation of the intestine and outlines principles and protocols for diagnostic and elimination diets.